Adherence beliefs among breast cancer patients taking tamoxifen.
about
Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancerOral antineoplastic agents: how do we care about adherence?Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?Patient perceptions about illness self-management in ANCA-associated small vessel vasculitis.A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL).Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancerOptimizing adherence to adjuvant imatinib in gastrointestinal stromal tumor.Ethnic disparities in adherence to breast cancer survivorship surveillance care.Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patientsCytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patientsAdherence to intravenous chemotherapy in African American and white women with early-stage breast cancerThe change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer.Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trialUnderstanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns FrameworkHousehold net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer.Understanding Statin Non-Adherence: Knowing Which Perceptions and Experiences Matter to Different Patients.Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income womenSymptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer.Patients with Complex Chronic Diseases: perspectives on supporting self-management.Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Catalonia, Spain.Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancerStructural equation modeling of the proximal-distal continuum of adherence drivers.The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy.Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communicationNon-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL).Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer.A Systematic Review of Adherence to Oral Antineoplastic TherapiesAdherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer.Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancerAdjuvant endocrine therapy in premenopausal women with breast cancer.Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancerPretreatment predictors of short-term nonadherence to oral hormonal therapy for women with breast cancer.Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancerA nested case-control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I-III breast cancer.Adjuvant hormonal therapy use among insured, low-income women with breast cancer.Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis.Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.Use of hormonal therapy in senior breast cancer patients treated with or without radiotherapy.Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review.
P2860
Q24632347-052079D4-2FE9-43C1-982E-60D41C9B9DEEQ28082909-AEC082BE-3C92-48BE-8E50-F6E88B7176EBQ33756969-4A68BFE4-78AA-4AB1-B3E1-C0C39AB6A3FDQ33854751-9897FC80-6C5F-4E1B-8789-C192D53066FDQ33857602-3887C9D9-3C5E-45F7-92E2-5F04167AF917Q33874887-BDAA24C1-6D6E-45A9-A0C4-A5D6F9EE3239Q33885999-AA7A923E-08E4-4632-A680-A7B99F6F99AEQ34025681-07A508C5-BD85-4D9A-83C8-205B5C847121Q34193946-91949E4D-38F1-44A7-9C31-1301FC1691B7Q34346501-BE7AB857-EEE4-479B-B72D-B9F84E9B7688Q34514230-DA1B4351-FA45-4D0D-9136-D28FCF23D45BQ34736154-550592E1-BEDF-45A7-AD33-D092DAE207D5Q34991931-836FA459-B13E-4DD1-AC31-C18072222CB1Q35061087-D1571638-708F-4C60-8227-8E35AAAA2ED4Q35168777-0EF888EF-66B3-4AE5-9E84-1D09A17805FBQ35903382-65F2A3A0-33D4-4BE8-B9F8-BD2BE752745FQ35968741-596FC543-0488-478B-B146-24AFDECBA095Q36064866-6A6EC454-6060-472A-96D4-6E4DFECC2EE8Q36293451-894D0747-9C96-41DB-9B71-ABC917CCF963Q36387779-622DB951-AEFA-4AEE-AF0D-576404B3C15FQ36406107-CE87F588-4BDA-4E97-AFD0-63F0F1C61FB6Q36429615-1C3D573B-08C9-4894-8153-F9065CBA65B9Q36459112-A2B85350-D95B-4F55-8741-9BDE7663FD3FQ36556940-31B00840-E5A9-4E05-98EB-6C19DC48C882Q36579191-67669D87-0E30-4E6D-93F3-52CB7BBDA30BQ36654489-8518B4B7-8C95-4F3C-8CE3-A098BC1C452CQ36673490-AA541268-7CEF-42B2-AF7F-5A230A17E69EQ36713559-3BB7D8F4-A484-49E0-B6A2-802811B3207CQ36788354-A2A83B1A-D4BB-4922-972A-09594FD68A90Q36858098-41FF9C8D-0600-456B-BE9C-84240C7D29C5Q36976772-8A2A8513-4F6F-4B2C-817E-A17CCAC3D7F1Q37010590-2EBF5D79-3674-4E58-BC34-9F1FFD253475Q37044668-E947B4C9-4EDD-494C-9FC4-DF73DC180312Q37076715-827834D7-F671-4D7A-93BD-C20A407931DFQ37182304-1340D724-B9FD-44B5-B228-42F668E0C330Q37280714-C56315FB-AEC4-4E65-81A8-00169C98EAFEQ37458977-BD9EA50C-4816-4A0D-B49D-231B0B607589Q37538355-539F0F41-B168-4BBD-8510-2DF024C48F48Q37577662-B7BDBBBD-E5BD-4A09-A08C-D662191B917AQ37669380-ABCD2D06-7B39-446C-B2C5-355C6D6E3B10
P2860
Adherence beliefs among breast cancer patients taking tamoxifen.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Adherence beliefs among breast cancer patients taking tamoxifen.
@ast
Adherence beliefs among breast cancer patients taking tamoxifen.
@en
Adherence beliefs among breast cancer patients taking tamoxifen.
@nl
type
label
Adherence beliefs among breast cancer patients taking tamoxifen.
@ast
Adherence beliefs among breast cancer patients taking tamoxifen.
@en
Adherence beliefs among breast cancer patients taking tamoxifen.
@nl
prefLabel
Adherence beliefs among breast cancer patients taking tamoxifen.
@ast
Adherence beliefs among breast cancer patients taking tamoxifen.
@en
Adherence beliefs among breast cancer patients taking tamoxifen.
@nl
P2093
P1476
Adherence beliefs among breast cancer patients taking tamoxifen.
@en
P2093
Elizabeth A Grunfeld
Myra S Hunter
Pooja Sikka
Sangeeta Mittal
P304
P356
10.1016/J.PEC.2004.10.005
P577
2005-10-01T00:00:00Z